as on December 3, 2025 at 2:29 am IST
Day's Low
Day's High
0.22%
Downside
6.19%
Upside
52 Week's Low
52 Week's High
26.33%
Downside
109.07%
Upside
Check Ars Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$929.2M
EPS (TTM)
-1.795
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-28.06
Industry PE ratio
0PEG Ratio
0EBITDA
-89.8M
Revenue (TTM)
142.8M
Profit Margin
-56.06%
Return On Equity TTM
-45.92%
Track how Ars Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Ars Pharmaceuticals Inc in the last 5 years
Lowest (-95.35x)
June 30, 2023
Industry (0.00x)
December 3, 2025
Today (-28.06x)
December 3, 2025
Highest (24.31x)
September 30, 2023
Today’s Price to Earnings Ratio: -28.06x
Compare market cap, revenue, PE, and other key metrics of Ars Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $929.2M | NA | -28.06 | -56.06% | |
| BUY | $44.1B | 422.91% | -16.34 | -264.83% | |
| BUY | $60.1B | 254.45% | 1420.5 | 1.36% | |
| BUY | $109.1B | 90.92% | 29.93 | 31.35% | |
| BUY | $79.5B | 48.75% | 17.98 | 32.13% |
The Ars Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ars Pharmaceuticals Inc investment value today
Current value as on today
₹72,540
Returns
Returns from Ars Pharmaceuticals Inc Stock
Dollar Returns*
₹6,118 (+6.12%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ars Pharmaceuticals Inc. Average target price of $28.67
Get share price movements and forecasts by analysts on Ars Pharmaceuticals Inc.
What analysts predicted
68.47%UPSIDE
Target Price
$28.67
Current Price
$9.04
Analyzed by
9 Analysts
Target
$28.67
Ars Pharmaceuticals Inc target price $28.67, a slight upside of 68.47% compared to current price of $9.04. According to 9 analysts rating.
Search interest for Ars Pharmaceuticals Inc Stock has increased by 319% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:319% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 7.97M → 32.50M (in $), with an average increase of 50.5% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 914.2% return, outperforming this stock by 884.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 185.2% return, outperforming this stock by 218.8%
Profit Down
![]()
Netprofit is down for the last 4 quarters, 49.93M → -51.15M (in $), with an average decrease of 71.4% per quarter
Price Dip
![]()
In the last 7 days, SPRY stock has moved down by -5.5%
| Organisation | Ars Pharmaceuticals Inc |
| Headquarters | 11682 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Healthcare |
| CEO | Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Daniel Relovsky | Senior Vice President of Marketing |
Ms. Lynda Harris | Vice President of Human Resources |
Mr. Harris Kaplan M.B.A. | Executive Vice President of Commercial Strategy |
Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL | Co-Founder, President, CEO & Director |
Mr. Brian T. Dorsey M.S. | Chief Operating Officer |
Ms. Kathleen D. Scott CPA | Chief Financial Officer |
Mr. Alexander A. Fitzpatrick Esq. | Chief Legal Officer & Secretary |
Dr. Sarina Tanimoto M.B.A., M.D. | Co-Founder & Chief Medical Officer |
Dr. Robert Bell Ph.D. | Co-Founder & Chief Science Officer |
Mr. Justin Chakma | Chief Business Officer |
Ars Pharmaceuticals Inc share price today is $9.04 as on at the close of the market. Ars Pharmaceuticals Inc share today touched a day high of $9.6 and a low of $9.02.
Ars Pharmaceuticals Inc share touched a 52 week high of $18.9 on and a 52 week low of $6.66 on . Ars Pharmaceuticals Inc stock price today i.e. is closed at $9.04,which is 52.17% down from its 52 week high and 35.74% up from its 52 week low.
Ars Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ars Pharmaceuticals Inc (SPRY) shares with as little as ₹89.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.35 in Ars Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ars Pharmaceuticals Inc share’s latest price of $9.04 as on December 3, 2025 at 2:29 am IST, you will get 1.1062 shares of Ars Pharmaceuticals Inc. Learn more about
fractional shares .